These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29664014)

  • 1. RIP kinase 1-dependent endothelial necroptosis underlies systemic inflammatory response syndrome.
    Zelic M; Roderick JE; O'Donnell JA; Lehman J; Lim SE; Janardhan HP; Trivedi CM; Pasparakis M; Kelliher MA
    J Clin Invest; 2018 May; 128(5):2064-2075. PubMed ID: 29664014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
    Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
    J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo.
    Polykratis A; Hermance N; Zelic M; Roderick J; Kim C; Van TM; Lee TH; Chan FKM; Pasparakis M; Kelliher MA
    J Immunol; 2014 Aug; 193(4):1539-1543. PubMed ID: 25015821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Zhong Y; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin HL; Zuo HX; Li MY; Ma J; Jin X
    Toxicol Lett; 2022 Mar; 356():75-88. PubMed ID: 34942311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis.
    Hou J; Ju J; Zhang Z; Zhao C; Li Z; Zheng J; Sheng T; Zhang H; Hu L; Yu X; Zhang W; Li Y; Wu M; Ma H; Zhang X; He S
    Cell Death Dis; 2019 Jun; 10(7):493. PubMed ID: 31235688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome.
    Duprez L; Takahashi N; Van Hauwermeiren F; Vandendriessche B; Goossens V; Vanden Berghe T; Declercq W; Libert C; Cauwels A; Vandenabeele P
    Immunity; 2011 Dec; 35(6):908-18. PubMed ID: 22195746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor.
    Delanghe T; Huyghe J; Lee S; Priem D; Van Coillie S; Gilbert B; Choi SM; Vandenabeele P; Degterev A; Cuny GD; Dondelinger Y; Bertrand MJM
    Cell Death Dis; 2021 Jul; 12(7):699. PubMed ID: 34262020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.
    Newton K; Dugger DL; Wickliffe KE; Kapoor N; de Almagro MC; Vucic D; Komuves L; Ferrando RE; French DM; Webster J; Roose-Girma M; Warming S; Dixit VM
    Science; 2014 Mar; 343(6177):1357-60. PubMed ID: 24557836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing Necroptosis Using an RIPK1 Kinase Inactive Mouse Model of TNF Shock.
    Zelic M; Kelliher MA
    Methods Mol Biol; 2018; 1857():125-134. PubMed ID: 30136236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RIPK1 is dispensable for cell death regulation in β-cells during hyperglycemia.
    Veli Ö; Kaya Ö; Varanda AB; Hildebrandt X; Xiao P; Estornes Y; Poggenberg M; Wang Y; Pasparakis M; Bertrand MJM; Walczak H; Annibaldi A; Cardozo AK; Peltzer N
    Mol Metab; 2024 Sep; 87():101988. PubMed ID: 39004142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.
    Hänggi K; Vasilikos L; Valls AF; Yerbes R; Knop J; Spilgies LM; Rieck K; Misra T; Bertin J; Gough PJ; Schmidt T; de Almodòvar CR; Wong WW
    Cell Death Dis; 2017 Feb; 8(2):e2588. PubMed ID: 28151480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIPK1 inhibits ZBP1-driven necroptosis during development.
    Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
    Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo.
    Shutinoski B; Alturki NA; Rijal D; Bertin J; Gough PJ; Schlossmacher MG; Sad S
    Cell Death Differ; 2016 Oct; 23(10):1628-37. PubMed ID: 27258786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination.
    Wei R; Xu LW; Liu J; Li Y; Zhang P; Shan B; Lu X; Qian L; Wu Z; Dong K; Zhu H; Pan L; Yuan J; Pan H
    Genes Dev; 2017 Jun; 31(11):1162-1176. PubMed ID: 28701375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis.
    Roderick JE; Hermance N; Zelic M; Simmons MJ; Polykratis A; Pasparakis M; Kelliher MA
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14436-41. PubMed ID: 25246544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death.
    Dondelinger Y; Delanghe T; Rojas-Rivera D; Priem D; Delvaeye T; Bruggeman I; Van Herreweghe F; Vandenabeele P; Bertrand MJM
    Nat Cell Biol; 2017 Oct; 19(10):1237-1247. PubMed ID: 28920952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
    Hannes S; Abhari BA; Fulda S
    Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.
    Rickard JA; O'Donnell JA; Evans JM; Lalaoui N; Poh AR; Rogers T; Vince JE; Lawlor KE; Ninnis RL; Anderton H; Hall C; Spall SK; Phesse TJ; Abud HE; Cengia LH; Corbin J; Mifsud S; Di Rago L; Metcalf D; Ernst M; Dewson G; Roberts AW; Alexander WS; Murphy JM; Ekert PG; Masters SL; Vaux DL; Croker BA; Gerlic M; Silke J
    Cell; 2014 May; 157(5):1175-88. PubMed ID: 24813849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
    Kearney CJ; Cullen SP; Clancy D; Martin SJ
    FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.